A consumer advocacy group has scrutinised some of the Most Favoured Nation (MFN) pricing deals the Trump administration has ...

Adding ITM will also give Telix a pipeline of follow-up radiopharma candidates, including clinical-stage diagnostics and ...

Beacon Therapeutics is preparing to file for approval of its gene therapy for eye disorder X-linked retinitis pigmentosa ...

ADARx Pharmaceuticals, a San Diego-based biotech developing siRNA therapies for various diseases, has announced the terms for ...

Facing considerable pressure in its diabetes and obesity franchises, Novo has revealed a plan to launch five or more ...

The recommendation by the CHMP sets up an EU approval in the coming weeks for Klygefa (gefurulimab), a dual-binding nanobody ...

The FDA has published the design of its expedited Investigational New Drug (IND) pilot, part of a plan to restore US competitiveness in clinical research, and will now accept applications to take part ...

Around 1,000 patients in England with a form of incurable breast cancer will be able to get access to AstraZeneca and Daiichi Sankyo's life-extending drug, Enhertu, via the NHS from today. Final draft ...

The Danish Group stated that the new corporate culture – dubbed 'The Novo Way' – centres around four Cs; namely, customer ...

Avalere Health was the most successful agency, winning three Golds, a Silver and the highly contested accolade of PMi Agency ...

Fayuvi is Ultragenyx's second approved gene therapy after Genglycos (pariglasgene brecaparvovec) for glycogen storage disease ...